Telo Genomics Corp Stock Cash Per Share
| TELO Stock | CAD 0.12 0.01 7.69% |
Telo Genomics Corp fundamentals help investors to digest information that contributes to Telo Genomics' financial success or failures. It also enables traders to predict the movement of Telo Stock. The fundamental analysis module provides a way to measure Telo Genomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Telo Genomics stock.
| Last Reported | Projected for Next Year | ||
| Cash Per Share | 0.01 | 0.07 |
Telo | Cash Per Share |
Telo Genomics Corp Company Cash Per Share Analysis
Telo Genomics' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Telo Genomics Cash Per Share | 0.0723 |
Most of Telo Genomics' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Telo Genomics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Telo Cash Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Telo Genomics is extremely important. It helps to project a fair market value of Telo Stock properly, considering its historical fundamentals such as Cash Per Share. Since Telo Genomics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Telo Genomics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Telo Genomics' interrelated accounts and indicators.
Click cells to compare fundamentals
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
Telo Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Telo Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Telo Genomics' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Telo Genomics could also be used in its relative valuation, which is a method of valuing Telo Genomics by comparing valuation metrics of similar companies.Telo Genomics is currently under evaluation in cash per share category among its peers.
Telo Genomics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Telo Genomics from analyzing Telo Genomics' financial statements. These drivers represent accounts that assess Telo Genomics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Telo Genomics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.7M | 7.2M | 23.4M | 21.0M | 17.7M | 13.2M | |
| Enterprise Value | 1.9M | 6.3M | 19.8M | 18.3M | 15.1M | 12.4M |
Telo Fundamentals
| Return On Equity | -1.69 | ||||
| Return On Asset | -0.87 | ||||
| Current Valuation | 7.68 M | ||||
| Shares Outstanding | 74.56 M | ||||
| Shares Owned By Insiders | 5.34 % | ||||
| Shares Owned By Institutions | 2.74 % | ||||
| Number Of Shares Shorted | 2.46 K | ||||
| Price To Book | 15.16 X | ||||
| EBITDA | (2.79 M) | ||||
| Net Income | (2.82 M) | ||||
| Cash And Equivalents | 24.25 K | ||||
| Total Debt | 32.5 K | ||||
| Current Ratio | 0.09 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (2.63 M) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Beta | 1.04 | ||||
| Market Capitalization | 8.95 M | ||||
| Total Asset | 2.93 M | ||||
| Retained Earnings | (25.12 M) | ||||
| Working Capital | 2.56 M | ||||
| Net Asset | 2.93 M |
About Telo Genomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Telo Genomics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Telo Genomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Telo Genomics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.